IPP Bureau
Piramal Pharma reports Q1 FY26 consolidated loss at Rs. 81.70 Cr
By IPP Bureau - July 29, 2025
Piramal Pharma has reported total income of Rs. 1,992.11 crores during the period ended June 30, 2025
Cohance Lifesciences appoints Yann D'Herve as CEO of CDMO Business
By IPP Bureau - July 29, 2025
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
Torrent Pharmaceuticals appoints Aman Mehta as MD
By IPP Bureau - July 29, 2025
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
Astec LifeSciences Q1 FY26 revenue up 30.3%
By IPP Bureau - July 29, 2025
The company reported consolidated EBITDA loss of Rs. 10.5 crore in Q1 FY26 as compared to loss of Rs. 45.3 crore in the same period last year
Healthians elevates Nishant Singhal as CEO
By IPP Bureau - July 28, 2025
Singhal brings a powerful blend of operational excellence, investor acumen, and visionary thinking
Syngene International appoints Gaurav Kushwaha as CTO
By IPP Bureau - July 28, 2025
Kushwaha previously served as Chief Digital & Information Officer at Jubilant Ingrevia Limited
Jubilant Biosys appoints Venugopala Reddy Pagadala as VP&CFO - CRDMO
By IPP Bureau - July 28, 2025
His career spans notable tenures at Syngene International Limited, Cipla, Nestlé, and Bharat Petroleum Corporation Limited
Laurus Labs allotted 531.77 acres of land by the Govt. of Andhra Pradesh
By IPP Bureau - July 28, 2025
The company has projected Rs. 5,630 crores of investment and to provide employment to 6,350 people in three phases over a period of eight years
10.18 Cr women screened for cervical cancer under Govt. schemes
By IPP Bureau - July 28, 2025
This achievement is part of the population-based initiative for screening, prevention, and management of Non-Communicable Diseases
UK journal publishes complex case of severe pan-drug resistant infection in US liver transplant patient successfully treated with Zaynich
By IPP Bureau - July 28, 2025
This case report is jointly authored by US clinicians from leading hospitals, Houston Methodist Hospital, Weill Cornell Medical College and Johns Hopkins
Akums’ Haridwar factory receives ANVISA GMP certification for sterile manufacturing plant
By IPP Bureau - July 28, 2025
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
GSK forges $12 billion alliance with Hengrui Pharma
By IPP Bureau - July 28, 2025
GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
Dr. Reddy’s re-appoints G V Prasad as Co-Chairman and Managing Director
By IPP Bureau - July 27, 2025
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
Granules India CEO K V Sitaram Rao resigns
By IPP Bureau - July 27, 2025
Dr. Rao has over 29 years of experience in manufacturing, R&D, business operations, and customer service
Sigachi Industries reports Q1 FY26 consolidated loss at Rs. 100.35 Cr
By IPP Bureau - July 27, 2025
Sigachi Industries has reported total income of Rs. 132.18 crores during the period ended June 30, 2025
